Intellia Therapeutics, Inc.
NASDAQ:NTLA
9.71 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.111 | 6.957 | 28.935 | -1.917 | 11.992 | 13.594 | 12.606 | 13.573 | 13.266 | 14.03 | 11.252 | 12.854 | 7.204 | 6.55 | 6.445 | 6.595 | 22.22 | 16.263 | 12.916 | 10.936 | 10.616 | 11.118 | 10.433 | 7.88 | 7.408 | 7.677 | 7.469 | 6.668 | 7.317 | 5.917 | 6.215 | 5.627 | 4.869 | 4.206 | 1.777 | 1.693 | 1.688 | 1.377 | 1.286 | 0 | 0 |
| Cost of Revenue
| 0 | 2.599 | 2.512 | 2.466 | 2.29 | 2.17 | 2.05 | 2.031 | 96.651 | 1.837 | 1.754 | 1.88 | 60.486 | 58.884 | 39.276 | 38.231 | 39.756 | 37.771 | 34.65 | 31.731 | 27.513 | 25.46 | 23.709 | 19.918 | 23.237 | 23.467 | 22.493 | 21.17 | 17.481 | 15.565 | 13.431 | 11.331 | 7.861 | 7.423 | 5.225 | 4.375 | 3.458 | 1.966 | 1.371 | 1.475 | 0.011 |
| Gross Profit
| 9.111 | 4.358 | 26.423 | -4.383 | 9.702 | 11.424 | 10.556 | 11.542 | -83.385 | 12.193 | 9.498 | 10.974 | -53.282 | -52.334 | -32.831 | -31.636 | -17.536 | -21.508 | -21.734 | -20.795 | -16.897 | -14.342 | -13.276 | -12.038 | -15.829 | -15.79 | -15.024 | -14.502 | -10.164 | -9.648 | -7.216 | -5.704 | -2.992 | -3.217 | -3.448 | -2.682 | -1.77 | -0.589 | -0.085 | -1.475 | -0.011 |
| Gross Profit Ratio
| 1 | 0.626 | 0.913 | 2.286 | 0.809 | 0.84 | 0.837 | 0.85 | -6.286 | 0.869 | 0.844 | 0.854 | -7.396 | -7.99 | -5.094 | -4.797 | -0.789 | -1.323 | -1.683 | -1.902 | -1.592 | -1.29 | -1.273 | -1.528 | -2.137 | -2.057 | -2.012 | -2.175 | -1.389 | -1.631 | -1.161 | -1.014 | -0.614 | -0.765 | -1.94 | -1.584 | -1.049 | -0.428 | -0.066 | 0 | 0 |
| Reseach & Development Expenses
| 123.38 | 111.608 | 109.335 | 108.981 | 113.696 | 115.276 | 97.116 | 100.034 | 96.651 | 90.199 | 133.095 | 71.161 | 60.486 | 58.884 | 39.276 | 38.231 | 39.756 | 37.771 | 34.65 | 31.731 | 27.513 | 25.46 | 23.709 | 19.918 | 23.237 | 23.467 | 22.493 | 21.17 | 17.481 | 15.565 | 13.431 | 11.331 | 7.861 | 7.423 | 5.225 | 4.375 | 3.458 | 1.966 | 1.371 | 4.502 | 0.011 |
| General & Administrative Expenses
| 30.501 | 31.793 | 31.091 | 28.994 | 29.403 | 30.652 | 27.448 | 23.626 | 22.145 | 22.132 | 22.403 | 22.108 | 18.711 | 16.683 | 13.594 | 10.763 | 10.566 | 11.526 | 11.314 | 8.976 | 8.431 | 13.118 | 10.533 | 8.708 | 8.27 | 7.805 | 7.406 | 10.213 | 5.711 | 6.369 | 5.732 | 5.118 | 4.705 | 3.729 | 3.246 | 2.809 | 1.531 | 2.833 | 1.11 | 2.715 | 0.167 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 30.501 | 31.793 | 31.091 | 28.994 | 29.403 | 30.652 | 27.448 | 23.626 | 22.145 | 22.132 | 22.403 | 22.108 | 18.711 | 16.683 | 13.594 | 10.763 | 10.566 | 11.526 | 11.314 | 8.976 | 8.431 | 13.118 | 10.533 | 8.708 | 8.27 | 7.805 | 7.406 | 10.213 | 5.711 | 6.369 | 5.732 | 5.118 | 4.705 | 3.729 | 3.246 | 2.809 | 1.531 | 2.833 | 1.11 | 2.715 | 0.167 |
| Other Expenses
| 0 | -114.207 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 153.881 | 143.401 | 140.426 | 137.975 | 143.099 | 145.928 | 124.564 | 123.66 | 118.796 | 112.331 | 155.498 | 93.269 | 79.197 | 75.567 | 52.87 | 48.994 | 50.322 | 49.297 | 45.964 | 40.707 | 35.944 | 38.578 | 34.242 | 28.626 | 31.507 | 31.272 | 29.899 | 31.383 | 23.192 | 21.934 | 19.163 | 16.449 | 12.566 | 11.152 | 8.471 | 7.184 | 4.989 | 4.799 | 2.481 | 5.742 | 0.167 |
| Operating Income
| -144.77 | -139.043 | -114.003 | -139.892 | -131.107 | -132.334 | -111.958 | -110.087 | -105.53 | -98.301 | -144.246 | -80.415 | -71.993 | -69.017 | -46.425 | -42.399 | -28.102 | -33.034 | -33.048 | -29.771 | -25.328 | -27.46 | -23.809 | -20.746 | -24.099 | -23.595 | -22.43 | -24.715 | -15.875 | -16.017 | -12.948 | -10.822 | -7.697 | -6.946 | -6.694 | -5.491 | -3.301 | -3.422 | -1.195 | -4.189 | -0.178 |
| Operating Income Ratio
| -15.89 | -19.986 | -3.94 | 72.974 | -10.933 | -9.735 | -8.881 | -8.111 | -7.955 | -7.006 | -12.82 | -6.256 | -9.993 | -10.537 | -7.203 | -6.429 | -1.265 | -2.031 | -2.559 | -2.722 | -2.386 | -2.47 | -2.282 | -2.633 | -3.253 | -3.073 | -3.003 | -3.707 | -2.17 | -2.707 | -2.083 | -1.923 | -1.581 | -1.651 | -3.767 | -3.243 | -1.956 | -2.485 | -0.929 | 0 | 0 |
| Total Other Income Expenses Net
| 9.058 | -7.932 | 6.567 | 7.731 | 8.883 | 8.653 | 8.832 | -3.32 | -7.699 | -2.377 | -2.626 | -0.822 | 0.349 | 0.211 | 0.22 | 0.207 | 0.262 | 0.641 | 1.242 | 1.495 | 1.694 | 1.777 | 1.869 | 1.68 | 1.397 | 1.376 | 1.074 | 0.752 | 0.519 | 0.424 | 0.317 | 0.259 | 0.215 | 0.046 | 0.005 | 0 | 0 | 0 | 0 | -3.028 | 0.011 |
| Income Before Tax
| -135.712 | -146.975 | -107.436 | -132.161 | -122.224 | -123.681 | -103.126 | -113.407 | -113.229 | -100.678 | -146.872 | -81.237 | -71.644 | -68.806 | -46.205 | -42.192 | -27.84 | -32.393 | -31.806 | -28.276 | -23.634 | -25.683 | -21.94 | -19.066 | -22.702 | -22.219 | -21.356 | -23.963 | -15.356 | -15.593 | -12.631 | -10.563 | -7.482 | -6.9 | -6.689 | -5.491 | -3.301 | -3.422 | -1.195 | -7.217 | -0.178 |
| Income Before Tax Ratio
| -14.895 | -21.126 | -3.713 | 68.942 | -10.192 | -9.098 | -8.181 | -8.355 | -8.535 | -7.176 | -13.053 | -6.32 | -9.945 | -10.505 | -7.169 | -6.398 | -1.253 | -1.992 | -2.463 | -2.586 | -2.226 | -2.31 | -2.103 | -2.42 | -3.065 | -2.894 | -2.859 | -3.594 | -2.099 | -2.635 | -2.032 | -1.877 | -1.537 | -1.641 | -3.764 | -3.243 | -1.956 | -2.485 | -0.929 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 2.469 | 40.635 | -15.03 | -14.823 | -10.782 | 3.32 | 5.865 | -0.703 | -0.119 | -2.383 | 0 | 0 | 0 | -1.602 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.227 | 0 | 0 | 0 | -0.833 | 0 | 0 | 0 | -0.405 | 0 | 0 | 0 | -0.246 | -0.282 | -0.382 | -0.102 | 0 | 0 |
| Net Income
| -135.712 | -146.975 | -107.436 | -132.161 | -122.224 | -123.681 | -92.344 | -116.727 | -113.229 | -99.975 | -146.872 | -81.237 | -71.644 | -68.806 | -46.205 | -42.192 | -27.84 | -32.393 | -31.806 | -28.276 | -23.634 | -25.683 | -21.94 | -19.066 | -22.702 | -22.219 | -21.356 | -23.963 | -15.356 | -15.593 | -12.631 | -10.563 | -7.482 | -6.9 | -6.689 | -5.245 | -3.019 | -3.04 | -1.093 | -7.217 | -0.178 |
| Net Income Ratio
| -14.895 | -21.126 | -3.713 | 68.942 | -10.192 | -9.098 | -7.325 | -8.6 | -8.535 | -7.126 | -13.053 | -6.32 | -9.945 | -10.505 | -7.169 | -6.398 | -1.253 | -1.992 | -2.463 | -2.586 | -2.226 | -2.31 | -2.103 | -2.42 | -3.065 | -2.894 | -2.859 | -3.594 | -2.099 | -2.635 | -2.032 | -1.877 | -1.537 | -1.641 | -3.764 | -3.098 | -1.789 | -2.208 | -0.85 | 0 | 0 |
| EPS
| -1.34 | -1.52 | -1.12 | -1.46 | -1.38 | -1.4 | -1.05 | -1.44 | -1.49 | -1.32 | -1.96 | -1.09 | -0.97 | -1.01 | -0.69 | -0.69 | -0.47 | -0.61 | -0.63 | -0.57 | -0.49 | -0.56 | -0.49 | -0.43 | -0.53 | -0.52 | -0.51 | -0.61 | -0.44 | -0.45 | -0.36 | -0.31 | -0.22 | -0.36 | -0.2 | -0.3 | -0.17 | -0.17 | -0.062 | -2.48 | -0.061 |
| EPS Diluted
| -1.34 | -1.52 | -1.12 | -1.46 | -1.38 | -1.4 | -1.05 | -1.44 | -1.49 | -1.32 | -1.96 | -1.09 | -0.97 | -1.01 | -0.69 | -0.69 | -0.47 | -0.61 | -0.63 | -0.57 | -0.49 | -0.56 | -0.49 | -0.43 | -0.53 | -0.52 | -0.51 | -0.61 | -0.44 | -0.45 | -0.36 | -0.31 | -0.22 | -0.36 | -0.2 | -0.3 | -0.17 | -0.17 | -0.062 | -2.48 | -0.061 |
| EBITDA
| -142.162 | -136.444 | -111.491 | -137.426 | -128.817 | -130.164 | -109.908 | -108.056 | -103.58 | -96.464 | -142.492 | -78.535 | -70.207 | -67.383 | -44.834 | -40.797 | -26.5 | -31.468 | -31.507 | -28.205 | -23.945 | -26.122 | -22.509 | -19.519 | -22.947 | -22.522 | -21.418 | -23.882 | -15.085 | -15.306 | -12.288 | -10.417 | -7.432 | -6.699 | -6.507 | -5.359 | -3.205 | -3.355 | -1.162 | -4.188 | 0 |
| EBITDA Ratio
| -15.603 | -19.612 | -3.853 | 71.688 | -10.933 | -9.735 | -8.873 | -7.711 | -7.219 | -7.019 | -12.626 | -6.256 | -9.746 | -10.287 | -6.956 | -6.429 | -1.193 | -1.935 | -2.439 | -2.578 | -2.256 | -2.351 | -2.158 | -2.633 | -3.098 | -2.934 | -2.868 | -3.707 | -2.062 | -2.587 | -1.977 | -1.923 | -1.526 | -1.593 | -3.662 | -3.165 | -1.899 | -2.436 | -0.904 | 0 | 0 |